ESR1 and breast carcinoma: Initially motivated to discover a prognostic genomic signature for the general breast cancer patient population, including patients with all cancer stages and ER/nodal status, we identified a 28-gene prognostic signature from a population-based breast cancer cohort [34] and validated it in more than 2000 patients with all cancer stages and ER statuses [35].